Immuneering Corporation (IMRX)
NASDAQ: IMRX · Real-Time Price · USD
5.02
+0.02 (0.40%)
Mar 3, 2026, 2:59 PM EST - Market open
Immuneering Market Cap
Immuneering has a market cap or net worth of $324.14 million as of March 3, 2026. Its market cap has increased by 461.25% in one year.
Market Cap
324.14M
Enterprise Value
92.10M
1-Year Change
461.25%
Ranking
Category
Stock Price
$5.02
Market Cap Chart
Since the IPO on July 30, 2021, Immuneering's market cap has decreased from $365.84M to $324.14M, a decrease of -11.40%. That is a compound annual growth rate of -2.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 2, 2026 | 322.85M | -24.01% |
| Dec 31, 2025 | 424.87M | 521.96% |
| Dec 31, 2024 | 68.31M | -68.25% |
| Dec 29, 2023 | 215.13M | 67.99% |
| Dec 30, 2022 | 128.06M | -69.91% |
| Dec 31, 2021 | 425.60M | 16.33% |
| Jul 30, 2021 | 365.84M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Protara Therapeutics | 340.81M |
| Sutro Biopharma | 335.46M |
| Relmada Therapeutics | 334.40M |
| Rezolute | 333.43M |
| Foghorn Therapeutics | 332.74M |
| Aldeyra Therapeutics | 328.49M |
| Avalo Therapeutics | 323.97M |
| Cabaletta Bio | 319.60M |